Requip XL and Breastfeeding

Although no studies have been done to see if Requip XL (ropinirole XL) passes through breast milk in women, it is expected that the drug would pass through breast milk based on its chemical structure. It is known that Requip XL can lower prolactin levels in humans, which could affect a woman's ability to breastfeed. If you are taking Requip XL and breastfeeding or plan to start, make sure to talk with your healthcare provider.

 

Is Requip XL Safe for Breastfeeding Women?

It is not known if Requip® XL (ropinirole XL) passes through breast milk in humans. Because of the potentially serious side effects that could occur in the nursing infant, the manufacturer of Requip XL recommends that women not take the medication while breastfeeding. Therefore, if you are breastfeeding a child, make sure to let your healthcare provider know.
 

What Does the Research Say?

Ropinirole (the active ingredient in Requip XL) passes through breast milk in rats. No research has been done to see if it also passes through breast milk in humans. However, based on the chemical structure of Requip XL, it is likely that this medication would pass through breast milk in humans.
 
Studies have shown that Requip XL can lower prolactin levels in humans. Because prolactin is a hormone that is important for breastfeeding, Requip XL could affect a woman's ability to breastfeed.
 

Talking With Your Healthcare Provider About Requip XL and Breastfeeding

You should talk with your healthcare provider about Requip XL and breastfeeding. Everyone's situation is different, and your healthcare provider understands your situation best. Based on what you want and expect, as well as your current health situation, you and your healthcare provider can make a shared decision about Requip XL and breastfeeding that is right for you.
 
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;